Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Shahbaz A. Malik, MD, Saul Yanovich, MD, Aaron P. Rapoport, MD, Ashraf Z Badros, MD, Nancy M. Hardy, MD, Mehmet H. Kocoglu, MD, Alison Duffy, Kathleen Ruehle, Jennifer Nishioka, Olga Goloubeva, PhD, Jean Yared, MD

Blood (2015) 126 (23): 5507.

https://doi.org/10.1182/blood.V126.23.5507.5507

Published: 2015

Journal Articles

Characteristics and Outcome Of Multiple Myeloma (MM) In African Americans (AA) Receiving Novel Agents and Autologous Stem Cell Transplantation (ASCT)

Vishal Bhatnagar, MD, Yin Wu, MD, Olga Goloubeva, Kathleen Ruehle, RN, Todd Milliron, Saul Yanovich, MD, Aaron P. Rapoport, MD, Ashraf Badros, MD

Blood (2013) 122 (21): 2951.

https://doi.org/10.1182/blood.V122.21.2951.2951

Published: 2013

Journal Articles

Engineered T-Cells Expressing An HLA-Restricted Affinity-Enhanced TCR In Advanced Multiple Myeloma Patients Post Auto-SCT Engraft and Are Associated With Encouraging Post Auto-SCT Responses

Blood (2013) 122 (21): 766.

https://doi.org/10.1182/blood.V122.21.766.766

Published: 2013

Journal Articles

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Blood (2012) 120 (21): 352.

https://doi.org/10.1182/blood.V120.21.352.352

Published: 2012

Journal Articles

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Blood (2012) 120 (21): 472.

https://doi.org/10.1182/blood.V120.21.472.472

Published: 2012

Journal Articles

Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1

Blood (2012) 120 (21): 755.

https://doi.org/10.1182/blood.V120.21.755.755

Published: 2012

Journal Articles

Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis

Gorgun Akpek, Maria Mikulski, Michael Kleinberg, Ashraf Badros, Saul Yanovich, Aaron P. Rapoport

Blood (2011) 117 (21): 5772–5774.

https://doi.org/10.1182/blood-2011-02-334060

Published: 2011

Journal Articles

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Blood (2011) 117 (3): 788–797.

https://doi.org/10.1182/blood-2010-08-299396

Published: 2011

Includes: Supplemental data

Journal Articles

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Blood (2009) 114 (22): 784.

https://doi.org/10.1182/blood.V114.22.784.784

Published: 2009

Journal Articles

Outcome of African-American (AA) Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplantation (ASCT): A Single-Center Experience.

Yin Wu, MD, Olga Goloubeva, PhD, Kathleen Ruehle, Saul Yanovich, MD, Aaron P. Rapoport, MD, Gorgun Akpek, MD, MS, Ashraf Z. Badros, MD

Blood (2008) 112 (11): 3327.

https://doi.org/10.1182/blood.V112.11.3327.3327

Published: 2008

Journal Articles

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Gorgun Akpek, MD, MHS, Ashraf Badros, MD, Aaron P. Rapoport, MD, Kathleen Ruehle, RN, Kristen Barton, RN, Barry Meisenberg, MD, Saul Yanovich, MD

Blood (2006) 108 (11): 5254.

https://doi.org/10.1182/blood.V108.11.5254.5254

Published: 2006

Journal Articles

Neurotoxicity of Bortezomib Therapy in Multiple Myeloma (MM): A Single Center Experience.

Ashraf Badros, MD, Jay S. Dalal, MD, Olga Goloubeva, PhD, Jenni Thompson, Phrm.D., Kelly Yager, RN, Can Ilyas, MD, Aaron P. Rapoport, MD, Robert G. Fenton, MD, PhD, Gorgun Akpek, MD, Saul Yanovich, MD, Edward Sausville, MD, PhD

Blood (2006) 108 (11): 3534.

https://doi.org/10.1182/blood.V108.11.3534.3534

Published: 2006

Journal Articles

Clinical Presentation, Prognostic Factors and Treatment Outcome of Multiple Myeloma (MM) in African American (AA) Patients.

Ashraf Z. Badros, MD, Olga Goloubeva, PhD, Saranya Chumsri, MD, Kathleen Ruehle, RN, Yi Ning, PhD, Joann Meekins, PhD, Liliana Guedez, PhD, Aaron P. Rapoport, MD, Barry Meisenberg, MD, Gorgun Akpek, MD, Saul Yanovich, MD, Edward Sausville, MD, PhD

Blood (2006) 108 (11): 5024.

https://doi.org/10.1182/blood.V108.11.5024.5024

Published: 2006

Journal Articles

Interruption of Bisphosphonates (BP) Therapy in Multiple Myeloma (MM) Patients and Osteonecrosis of the Jaw (ONJ).

Ashraf Badros, MD, Olga Goloubeva, PhD, Dianna Weikel, DDS, Aaron P. Rapoport, MD, Gorgun Akpek, MD, Saul Yanovich, MD, Timothy Meiller, DDS, PhD, Edward Sausville, MD, PhD

Blood (2006) 108 (11): 5026.

https://doi.org/10.1182/blood.V108.11.5026.5026

Published: 2006

Journal Articles

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation

Steven Z. Pavletic, Shelly L. Carter, Nancy A. Kernan, Jean Henslee-Downey, Adam M. Mendizabal, Esperanza Papadopoulos, Roger Gingrich, James Casper, Saul Yanovich, Daniel Weisdorf, for the members of the National Heart, Lung, and Blood Institute Unrelated Donor Marrow Transplantation Trial

Blood (2005) 106 (9): 3308–3313.

https://doi.org/10.1182/blood-2005-04-1614

Published: 2005

Journal Articles

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Elizabeth J. Shpall, Catherine A. Wheeler, Stewart A. Turner, Saul Yanovich, Randy A. Brown, Andrew L. Pecora, Thomas C. Shea, Kenneth F. Mangan, Stephanie F. Williams, C. Fred LeMaistre, Gwynn D. Long, Roy Jones, Mark W. Davis, Robyn Murphy-Filkins, William R.L. Parker, John A. Glaspy

Blood (1999) 93 (8): 2491–2501.

https://doi.org/10.1182/blood.V93.8.2491

Published: 1999

NARROW

Outcome Comparison of Lymphoma and Myeloma Patients after Autologous Stem Cell Transplantation (ASCT) with Peripheral Blood Stem Cell Mobilization Between Plerixafor (P) Mobilized in Poor Mobilizer Patients and Non-Plerixafor Mobilized Patients

Characteristics and Outcome Of Multiple Myeloma (MM) In African Americans (AA) Receiving Novel Agents and Autologous Stem Cell Transplantation (ASCT)

Engineered T-Cells Expressing An HLA-Restricted Affinity-Enhanced TCR In Advanced Multiple Myeloma Patients Post Auto-SCT Engraft and Are Associated With Encouraging Post Auto-SCT Responses

Combination Immunotherapy After ASCT for Multiple Myeloma (MM) Using MAGE-A3/Poly-ICLC Immunizations Followed by Vaccine-Primed and Activated Autologous T-Cells

Adoptive Transfer of Gene-Modified T-Cells Engineered to Express High-Affinity TCRs for Cancer-Testis Antigens (CTAs) NY-ESO-1 or Lage-1, in MM Patients Post Auto-SCT

Prolonged T Cell Persistence, Homing to Marrow and Selective Targeting of Antigen Positive Tumor in Multiple Myeloma Patients Following Adoptive Transfer of T Cells Genetically Engineered to Express an Affinity-Enhanced T Cell Receptor Against the Cancer Testis Antigens NY-ESO-1 and Lage-1

Cellular therapy with sequential unmanipulated donor lymphocyte infusions in drug-resistant cytomegalovirus (CMV) encephalitis

Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma

Schedule Dependent Effects of Adoptively Transferred Autologous T Cells After AutoSCT for Myeloma: Accelerated Immune Recovery Is Associated with Improved Event-Free Survival.

Outcome of African-American (AA) Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplantation (ASCT): A Single-Center Experience.

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Neurotoxicity of Bortezomib Therapy in Multiple Myeloma (MM): A Single Center Experience.

Clinical Presentation, Prognostic Factors and Treatment Outcome of Multiple Myeloma (MM) in African American (AA) Patients.

Interruption of Bisphosphonates (BP) Therapy in Multiple Myeloma (MM) Patients and Osteonecrosis of the Jaw (ONJ).

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation

A Randomized Phase 3 Study of Peripheral Blood Progenitor Cell Mobilization With Stem Cell Factor and Filgrastim in High-Risk Breast Cancer Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only